Evidence map›Paper›PMID 36712662›Full record

ArticleFrontiers in pharmacology2022

Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China.

Qiyou Wu, Zhiwei Lian, Xin Wang, Hanchao Cheng, Jing Sun, Hui Yu, Gong Zhang, Fan Wu, Jian Liu, Chuanben Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Qiyou WuSchool of Health Policy and Management, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Zhiwei LianClinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Xin WangSchool of Health Policy and Management, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Hanchao ChengSchool of Health Policy and Management, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Jing SunSchool of Health Policy and Management, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Hui YuClinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Gong ZhangClinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Fan WuClinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Jian LiuClinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chuanben ChenClinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Fujian Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biosimilarbreast cancerpatientphysicianuptake

Identifiers

PMID36712662
PMCPMC9877225
OpenAlexW4315796544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.